Aesthetic Breast Surgery Concenpts & Techniques Elizabeth Findlay

Index
Anesthesia

for augmentation, 180 for liposuction-only breast reduction, 391

for pucker correction, 293, 295,

310

for vertical breast reduction, 281 Antibiotics

in breast augmentation, 185, 194 in vertical breast reduction, 298-299 Areola

depigmentation of, 322 necrosis of, after breast re-reduction, 410-412 opening

in mastopexy, 474-475 in mastopexy-augmentation, 547-548

in vertical breast reduction, 276, 288

size of, 659-661 spreading of, 229, 569-570 tuberous breast deformity' correction, 681

Arterial supply description of, 76

internal mammary' system; see Internal mammary' system lateral thoracic artery, 82 thoracoacromial artery', 83 As^nmetry

chest wall deformities, 674-677 developmental; see Developmental asymmetry

laterally sloping chest wall as cause of, 161-162

lipodystrophy syndrome as cause of, 702-703 overview of, 638 patient discussions about, 141 Poland’s syndrome as cause of, 698-700

reduction as cause of, 306-308 sternal prominence as cause of, 163, 179
surgical correction of

areolar size considerations, 659-661

augmentation, 159-163, 668, 670, 673-674

breast shape evaluations, 647-651

breast size considerations, 639-661

capsular contracture after, 664-665

footprint evaluations, 640-646 infection after, 666 mastopexy, 669-670 mastopexy-augmentation, 671 nipple position considerations, 652-658

problems and complications associated with, 661-666 reduction, 667, 669, 672 results, 666-674 revision surgery', 661-665, 703 surgical decision making for, 141 tuberous breast deformity; see Tuberous breast deformity' Turner’s syndrome as cause of, 701 vertical breast reduction as cause of, 306-308 Augmentation

anesthesia for, 180 antibiotics, 185, 194 asymmetry' corrections with, 159-163,668,670,673-674 bandaging used in, 186-187 bilateral, 691

breast shape changes, 155-158 case studies of, 230-240 clinical outcomes of, 148-163 considerations for, 118 dissection, 182 drains, 186 follow-up after, 188 footprint affected by, 149-154 hemostasis during, 189 in high-breasted patients, 148
implants

bottoming out of, 221-222, 579 choices, 164-166 complications and problems associated with, 194-204, 215-217 displacement of, 222-228 double capsules, 200-204 edge visibility, 195 exposure of, 220 extrusion of, 194 federal limitations on choice of, 164

folds in, 196-198 fracture of, 171, 198 malposition of, 221-228 padding of, 195 placement of, 174-176, 195 povidone-iodine soaking of, 184 problems associated with, 194-204 rippling of, 195 rugae formation, 199 rupture of, 192, 215-217 saline, 171,215-217 silicone, 164-166, 217 size of, 167-168 subfascial placement of, 174 subglandular placement of, 174-176

subpectoral placement of, 174-176 tissue adherence to, 198-199 tissue ingrowth, 198 incisions

crescent, 172-173 infraareolar, 170 inframammary, 168-170, 176 marking of, 177 periareolar, 170-171 transaxillary, 171-172 inframammary' fold changes, 24, 151,222,237, 522 lateral breast border changes, 152 in low-breasted patients, 148, 234 markings and design for, 176-178 mastopexy and; see Mastopexy-augmentation
1-1